Pack size: 1 1 vial + diluent  |  Price is for the whole 1 vial + diluent

⚠ Prescription required. This medicine may only be dispensed against a valid prescription.

Generic: Meningococcal polysaccharide ACWY Vaccine

Form: Injection

Indication

Indicated for the active immunization of children from 2 years of age, adolescents and adults against meningococcal disease caused by meningococci of serogroups A, C, W135 and Y. The vaccine may also be used for: Subjects who are living in closed communities and close contacts of patients with disease caused by meningococci of serogroups A, C, W135 and Y. Travellers to countries where the disease is epidemic or highly endemic.

Administration

Administer IM only; do not administer IV, SC, or ID Give IM injection, preferably into the anterolateral aspect of the thigh in infants or into the deltoid muscle in toddlers, adolescents, and adults

Adult Dose

The recommended dose for vaccines in all age groups is 0.5mL, administered as a single dose. Vaccine is administered subcutaneously as a single 0.5 ml dose. Protective antibody levels may be achieved within 7 to 10 days after vaccination.

Child Dose

The recommended dose for vaccines is 0.5mL, administered as a single dose. Children from 2 years of age, vaccine is administered subcutaneously as a single 0.5 ml dose. Protective antibody levels may be achieved within 7 to 10 days after vaccination. Revaccination of a single 0.5 ml dose administered subcutaneously may be indicated for individuals at high-risk of infection, particularly children who were first vaccinated when they were less than 4 years of age; such children should be considered for revaccination after 2 or 3 years if they remain at high-risk.

Contraindication

Severe allergic reaction (eg, anaphylaxis) after a previous dose of a meningococcal capsular polysaccharide-, diphtheria toxoid- or CRM197-containing vaccine, or to any component.

Mode of Action

Meningococcal serogroup A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid protein carrier. These products convey active immunity via stimulation of production of endogenously produced antibodies.